SHCSotera Health Company
Price
+16%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, price roughly fair, growth steady, the market undecided.
We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. We are driven by our mission: Safeguarding Global Health®. We provide end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers in the United States and around the world.
In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Sotera Health Company (SHC) reported revenue of $321M in Q2 2026 (quarter ended Jun 30, 2026), up 9.2% from the same quarter a year earlier. That came with a gross margin of 55% and net income of $54M (17% of revenue). For the full year FY2025, revenue was $1.16B (+5.7% year on year) and net income $78M. Its largest segment in Q2 2026 was Sterigenics at $212M, 82% of the disclosed total, well ahead of Nordion at 18%. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 14, 2026On August 11, 2026, James C. Neary notified the Board of Directors (the “Board”) of Sotera Health Company (the “Company”) of his resignation as a Class I director, effective August 13, 2026 (the “Effective Date”)Director or officer change · Form 8-K
- Aug 6, 2026Sotera Health Delivers Strong Second-Quarter and.Earnings release · press release
- May 20, 2026Credit Agreement On May 20, 2026, Sotera Health Company (the “Company”), Sotera Health Holdings, LLC (“SHH”), certain subsidiaries of the Company, each 2026 Refinancing Term Lender (the “Refinancing Lenders”) and JPMorgan Chase Bank, N.A., as first lien Administrative Agent (the “Administrative Agent”) entered into …Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Q2 2026 · $258.8MThe company’s own SEC segment disclosure.
- Sterigenics$211.6M82%
- Nordion$47.2M18%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Diagnostics & Research
Ranks #4 of 21 by RyuScore